Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Gene Variant Increases Risk of Age-Related Macular Degeneration

11.03.2005


Researchers at Duke University Medical Center and Vanderbilt University Medical Center have pinpointed the first major gene that determines an individual’s risk for developing age-related macular degeneration (AMD). The chronic, progressive disease -- which affects as many as 15 million people in the United States -- is the leading cause of visual impairment and legal blindness in the elderly.



A common variant of the gene, called complement factor H (CFH), explains approximately 43 percent of the risk of AMD among older adults, the researchers estimated. The team identified the disease-related gene after screening 182 families affected by AMD and 495 other individuals with the condition. The researchers will report their findings in a forthcoming issue of Science (published online March 10, 2005, in Science Express).

The genetic advance sheds light on the mechanisms underlying the disease and could lead to new avenues for treatment, the researchers said. The finding might also yield methods for identifying those patients at the greatest risk for developing the condition before symptoms arise, when therapies and changes in lifestyle might be most effective in slowing the disease progression. "Macular degeneration is an important cause of blindness and loss of independence in the elderly," said Margaret Pericak-Vance, Ph.D., director of the Duke Center for Human Genetics and senior author of the report. "This gene opens the door to a whole new understanding of the factors that contribute to this disease. "The finding may ultimately lead to new methods for identifying those at high risk for macular degeneration and suggests new pathways for drug development," she added.


AMD causes progressive impairment of central vision, and is the most common cause of legal blindness in Americans over the age of 55. The disease causes damage to the retina, a thin layer of nervous tissue that lines the inside of the eye. The primary site of damage occurs in the central retina, a portion called the macula.

The retina functions like film in a camera, explained ophthalmologist Eric Postel, M.D., of the Duke University Eye Center. Without proper retinal function, images cannot be captured and sent to the brain. The macula is critical for fine, detailed vision. In patients with severe AMD, progressive blurring and loss of central vision due to damage of the macula may leave people unable to perform everyday activities such as driving, reading, writing checks and recognizing faces, he said. "Fifteen million people in the United States have AMD and 1.5 million have the most severe form," said Postel, the head clinician on the study. "By the year 2030, as the baby boomer generation ages, the number of people with AMD is expected to double."

AMD exists in two forms: the "dry" form and more severe "wet" form. In the dry form, degeneration of the macula can cause slow, progressive vision loss over the course of months to years. While there is no cure, vitamin supplements have been shown to slow the disease in some individuals with this milder form.

In ten percent of patients, the disease progresses to the wet form in which abnormal blood vessels under the macula leak blood and fluid causing rapid damage and a precipitous loss of vision. Patients with wet AMD can receive several treatments to prevent further vision loss -- including laser surgery and recently approved injections of a drug into the eye. However, available therapies usually can only stall the disease progression, Postel said. None effectively reverse the course of the disease.

While the underlying causes of AMD had remained largely unknown, risk factors include age, smoking, high blood pressure, obesity and diet, said Pericak-Vance. In addition to such environmental factors, evidence from family and twin studies had indicated a significant genetic contribution to the disease, she added.

Earlier studies by the Duke and Vanderbilt teams and others had linked AMD risk to a particular region on chromosome 1. To identify the gene responsible, the researchers examined two independent data sets: the first contained 182 families including members with and without AMD and the second contained 495 individuals with AMD and 185 unrelated individuals not affected by the disease.

The researchers zeroed in on a smaller region of chromosome 1 with a strong association to the disease in both data sets. Further DNA sequencing of the CFH gene that is within that region revealed that individuals with one or more copies of a particular gene variant were more likely to have AMD compared to those with other versions of the gene, they reported. When the researchers restricted the analysis to individuals with the more severe, wet form of AMD, the association between the gene variant and the disease became even stronger.

The researchers estimated that the CFH variant may be responsible for up to 43 percent of all cases of AMD. Earlier studies had suggested that CFH may play a role in protecting blood vessels from inflammation and damage, a function which might explain its role in AMD, the researchers said. "We knew that chronic inflammation played a role in macular degeneration, but we didn’t know if that was a primary cause of the disease or a secondary symptom," said Jonathan Haines, Ph.D., of Vanderbilt Center for Human Genetics Research and first author on the report. "The finding that complement factor H is an important contributor to the disease suggests that inflammation may be a more important aspect of the disease than had previously been appreciated."

Given that the gene plays such a large role in AMD, further studies of CFH and the cellular components with which it interacts might lead to a rapid increase in understanding of the biology of the disease, the researchers added. That information, in turn, should allow scientists to advance on new treatments and preventive therapies.

Collaborators on the study include Michael Hauser, Silke Schmidt, William Scott, Paul Gallins, Shu Ying Kwan, Maher Noureddine and John Gilbert, of the Duke Center for Human Genetics; Lana Olson, Kylee Spencer, Nathalie Schnetz-Boutaud and Anita Agarwal, of the Vanderbilt University Medical Center. The National Eye Institute supported the work. Additional resources came from the National Institute on Aging and the National Center for Research Resources to Vanderbilt University.

Kendall Morgan | EurekAlert!
Further information:
http://www.duke.edu

More articles from Life Sciences:

nachricht Staying in Shape
16.08.2018 | Max-Planck-Institut für molekulare Zellbiologie und Genetik

nachricht Chips, light and coding moves the front line in beating bacteria
16.08.2018 | Okinawa Institute of Science and Technology (OIST) Graduate University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

Staying in Shape

16.08.2018 | Life Sciences

Diving robots find Antarctic seas exhale surprising amounts of carbon dioxide in winter

16.08.2018 | Earth Sciences

Protein droplets keep neurons at the ready and immune system in balance

16.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>